Damdamon, Bajari D.

HRN: 23-66-01  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2025
CEFTRIAXONE 1G (VIAL)
06/08/2025
06/14/2025
IVT
800mg
Q24
AGE With Moderate Dehydration
Waiting Final Action 
06/08/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/08/2025
06/15/2025
ORAL
3ml
Q8
AGE With Moderate Dehydration
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: